Search Saint Luke's

Asian individuals experience poorer outcomes after out-of-hospital cardiac arrest in the U.S. compared with white individuals, despite similar rates of bystander CPR.

A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Health Central sat down with cardiologist Tracy Stevens, MD, the medical director of Saint Luke's Muriel I. Kauffman Women’s Heart Center, to discuss warning signs of hypertension and when it's time to see a doctor.

The intent of these exchanges is to provide caregivers with secure access to patient health information so they can render the most effective care regardless of where the patient seeks that care.

Dr. Matthew Wilkinson, a transplant surgeon at Saint Luke’s talks about the advances in organ donation and the importance of living organ donation.

Recent advances in breast cancer treatment are showing promise for those with advanced cancer to live longer, better quality lives.

Cardiologist Elizabeth Grier, MD, shares how Saint Luke’s Valve and Structural Heart Center stays on the leading edge of advances in treatment for various heart valve disease conditions.

A recent study shows that stroke-related deaths will rise among millennials as they get older. Researchers suggest that obesity and diabetes could be a cause.